Clinical trial
A Prospective, Multi-center and Objective Performance Criteria Study to Evaluate the Effectiveness and Safety of NoYA™ Radiofrequency Interatrial Shunt System for the Treatment of Chronic Heart Failure With Elevated Left Atrial Pressure
NCT05375110 is registered in ClinicalTrials.gov with Hangzhou NOYA MedTech Co. Ltm. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multi-center and Objective Performance Criteria Study to Evaluate the Effectiveness and Safety of NoYA™ Radiofrequency Interatrial Shunt System for the Treatment of Chronic Heart Failure With Elevated Left Atrial Pressure
- Lead sponsor
- Hangzhou NOYA MedTech Co. Ltm.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 10, 2021
- Completion date
- December 31, 2023
- Enrollment
- 120 (estimated)
- Sites
- 31
Conditions
As the registry lists them; a condition with its own page is linked.